News at Pharmaplaz Ireland
Taoiseach, Mr. Bertie Ahern, T.D., Unveils Model for Bio-Healthcare Park at Groundbreaking Ceremony for Samaritan's Collaborative Partner Pharmaplaz, Ireland
An Taoiseach, Mr. Bertie Ahern, T.D, unveils research park model to mark the commencement of Pharmaplaz's new Bio-Healthcare Park projected to commence operations by the end of 2007. Samaritan is proposing its HIV drug SP-01A upon approval will be manufactured in the new park. This will be the largest industrial development adter Elan in Athlone, Ireland, and the seven-winged facility will employ more than 300 people in the next three to five years.
Samaritan Pharmaceuticals Inc., a developer of innovative drugs, announced today its collaborative manufacturing partner Pharmaplaz is breaking ground on a new Bio-Healthcare Park that will manufacture healthcare products for multinational healthcare companies. Currently, Pharmaplaz manufactures clinical study drugs for Samaritan and is extensively involved in the CMC section of Samaritan's clinical development of SP-01A, an oral HIV entry inhibitor.
An Taoiseach, Mr. Bertie Ahern, T.D., stated, "Pharmaplaz has proven the ability of Irish entrepreneurs to identify key growth markets. In addition, Pharmaplaz has demonstrated how our favorable tax regime can be used to the best effect in building a business."
"The master collaboration agreement between Samaritan and Pharmaplaz is a vote of confidence in the ability of Irish companies to provide the expertise and support for larger companies working in the bio-pharma sector. I have no doubt that the collaboration between Pharmaplaz and Samaritan will prove to be a very productive relationship."
Dr. Janet Greeson, CEO of Samaritan, stated, "Pharmaplaz has all the distinguishing characteristics of a great company. It never stops trying to improve, seek new challenges and new adventures. We celebrate this achievement for them and look forward to many more milestone achievements with them in the journey to making a difference in the lives of suffering patients."
